Skip to content

Effects of Concurrent HIIT and WB-EMS Exercise on the Cardiometabolic Risk Profile in Obese Individuals

Effects of Concurrent High-Intensity Interval Training and Whole-Body Electromyostimulation on the Cardiometabolic Risk Profile in Obese Individuals at Increased Risk for the Metabolic Syndrome

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03710447
Enrollment
100
Registered
2018-10-18
Start date
2018-10-15
Completion date
2021-10-30
Last updated
2018-10-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metabolic Syndrome, Overweight and Obesity

Keywords

Cardiometabolic Health, Cardiorespiratory Fitness, Muscular Strength, Body Composition, Inflammation, Aerobic Exercise, Resistance Exercise

Brief summary

The main purpose of this study is to compare the impact of concurrent high-intensity interval training (HIIT) and whole-body electromyostimulation exercise (WB-EMS) or low-volume conventional strength training (CST) on the cardiometabolic risk profile, overall physical fitness (cardiorespiratory fitness and muscular strength), body composition, inflammatory markers and subjective health outcomes after a 12-week intervention trial in overweight individuals at increased cardiometabolic risk. Furthermore, this study aims to investigate the influence of intra-session exercise order on all outcomes.

Interventions

OTHERHIIT + WB-EMS

12-week supervised exercise program consisting of ergometer-based high-intensity interval training (HIIT) and whole-body electromyostimulation (WB-EMS). HIIT: 5x1 min at 85-95% HRmax divided by low-intensity recovery periods. WB-EMS: Simulanteous stimulation of all major muscle groups with dedicated individual intensity. 2 exercise sessions per week. Order of application: HIIT - WB-EMS. Additionally, participants receive individualized nutritional counseling.

OTHERWB-EMS + HIIT

12-week supervised exercise program consisting of whole-body electromyostimulation (WB-EMS) and ergometer-based high-intensity interval training (HIIT). WB-EMS: Simulanteous stimulation of all major muscle groups with dedicated individual intensity. HIIT: 5x1 min at 85-95% HRmax divided by low-intensity recovery periods. 2 exercise sessions per week. Order of application: WB-EMS - HIIT. Additionally, participants receive individualized nutritional counseling.

OTHERHIIT + CST

12-week supervised exercise program consisting of ergometer-based high-intensity interval training (HIIT) and conventional low-volume strength training(CST). HIIT: 5x1 min at 85-95% HRmax divided by low-intensity recovery periods. CST: Conventional 1-set strength training using weight machines to train all major muscle groups with an individual intensity corresponding to 70-80% of one repetition maximum. 2 exercise sessions per week. Order of application: HIIT - CST. Additionally, participants receive individualized nutritional counseling.

OTHERCST + HIIT

12-week supervised exercise program consisting of conventional low-volume strength training(CST) and ergometer-based high-intensity interval training (HIIT). CST: Conventional 1-set strength training using weight machines to train all major muscle groups with an individual intensity corresponding to 70-80% of one repetition maximum. HIIT: 5x1 min at 85-95% HRmax divided by low-intensity recovery periods. 2 exercise sessions per week. Order of application: CST - HIIT. Additionally, participants receive individualized nutritional counseling.

Sponsors

University of Erlangen-Nürnberg Medical School
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Masking description

Outcome Assessors involved in data analysis will not be aware of the arm to which the participants were allocated (single-blinded masking).

Intervention model description

Parallel Assignment parallel-group, randomized-controlled study

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Body Mass Index \>25 * presence of at least 2 cardiometabolic risk factors

Exclusion criteria

* Healthy persons or patients under age * Overweight persons without any additional cardiometabolic risk factors * Pregnancy, Lactation * Psychological disorders, epilepsy, sever neurological disorders * Participation in other exercise- or nutrition studies within the last 6 months * acute cardiovascular disease * malignant disease * Electronic implants (defibrillator, pacemaker) * Persons in mental hospitals by order of authorities or jurisdiction

Design outcomes

Primary

MeasureTime frameDescription
Change in Metabolic Syndrome Z-Score (MetS-Z-Score).12 weeksMetS-Z-Score will be calculated from each individual's measures of waist circumference, mean arterial blood pressure, triglycerides, and HDL-cholesterol, based on equations specific to sex.
Change in overall Physical Fitness Score (PFS)12 weeksPFS is calculated from VO2max and 1 Repmax values of 5 major muscle Groups.

Secondary

MeasureTime frameDescription
Change in HOMA-IR12 weekInsulin resistance will be estimated using homeostasis model assessment index (HOMA)
Change Inflammation status12 weeksInflammation will be assessed by measuring levels of inflammatory blood markers (CRP, inflammatory cytokines)
Change in Perceived stress12 weeksPerceived stress will be assessed by using the standardized and validated Perceived Stress Questionnaire (PSQ)
Change in Pain scores12 weeksPain scores will be assessed by using the standardized and validated Chronic Pain Grade Questionnaire (CPGQ)
Change Subjective work ability12 weeksSubjective work ability will be assessed by using the standardized and validated Work Ability Index Questionnaire (WAI)
Change in Health-related quality of life12 weeksHealth-related quality of life will be assessed by using the standardized and validated EQ-5D-5L Questionnaire
Change in Body Composition12 weeksMuscle mass, fat mass and body water will be measured by Bioelectrical Impedance Analysis (BIA)

Countries

Germany

Contacts

Primary ContactDejan Reljic, Dr.
dejan.reljic@uk-erlangen.de+49 9131 8545218
Backup ContactYurdaguel Zopf, Prof.
yurdaguel.zopf@uk-erlangen.de+49 9131 8545218

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026